Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28417471 | 0.98 | CYP1A2 (0.33) | NAAACYP1A2CYP2D6CYP2C19 | |
| SCHEMBL28890647 | 0.88 | NAAA (0.39) | NAAAEPHX1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL28417541 | 0.86 | NAAA (0.37) | NAAACYP1A2CYP2D6CYP2C19 | |
| SCHEMBL28481136 | 0.83 | EPHX1 (0.34) | NAAAEPHX1 | |
| SCHEMBL23494124 | 0.82 | NAAA (0.41) | NAAAEPHX1CYP1A2 | |
| SCHEMBL3886752 | 0.79 | EPHX1 (0.37) | NAAAEPHX1 | |
| SCHEMBL11205257 | 0.78 | EPHX1 (0.34) | NAAAEPHX1 | |
| Water SCHEMBL28105373 | 0.77 | EPHX1 (0.33) | NAAAEPHX1 | |
| SCHEMBL20720478 | 0.76 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL19952926 | 0.74 | CA1 (0.36) | EPHX1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115806637-B | Catalyst system for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-111856882-B | Composition for forming silicon-containing resist underlayer film and pattern forming method | 信越化学工业株式会社 | 2024-11-29 | — | — | CN | disclosed |